Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as Adjuvant for Obturator Nerve Block
NCT02066727Completed
- Start
- Feb 2014
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in bladder cancer (2 arms). Primary endpoint: Median Effective Concentration of Lidocaine. Started Feb 2014; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT02066727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02066727.